|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/17 | |
| C12M 1/00 | |||
| G01N 33/569 | |||
| A61K 35/12 | |||
| C12N 5/0781 | |||
| C12N 5/0783 |
| (11) | Patento numeris | 3134514 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15721094.9 |
| Europos patento paraiškos padavimo data | 2015-04-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/027401 |
| Data | 2015-04-23 |
| (87) | Numeris | WO 2015/164675 |
| Data | 2015-10-29 |
| (30) | Numeris | Data | Šalis |
| 201461983415 P | 2014-04-23 | US |
| (72) |
RAMSBORG, Chris, US
BONYHADI, Mark, L., US
CHAN, Calvin, US
BEAUCHESNE, Pascal, US
|
| (73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109-4703,
US
|
| (54) | METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY |
| METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY |